Product
SHR-1703
Aliases
SHR-1703 Placebo
5 clinical trials
3 indications
Indication
AsthmaIndication
Churg-Strauss SyndromeIndication
Eosinophilic asthmaClinical trial
Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of a Single Subcutaneous Injection of SHR-1703 in Patients With Asthma -- a Randomized, Double-blind, Dose-increasing, Placebo Controlled Phase I Clinical StudyStatus: Active (not recruiting), Estimated PCD: 2023-06-15
Clinical trial
A Randomised, Double Blind, Placebo Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1703 Injection Administered Subcutaneously in Healthy SubjectsStatus: Completed, Estimated PCD: 2021-09-21
Clinical trial
A Single-arm/Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2/3 Clinical Study to Evaluate the Efficacy and Safety of SHR-1703 for Patients With EGPAStatus: Recruiting, Estimated PCD: 2026-03-21
Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase II Clinical Study to Evaluate the Pharmacodynamic, Efficacy and Safety of Multiple Subcutaneous Injections of SHR-1703 in Asthma Patients With Eosinophil PhenotypeStatus: Active (not recruiting), Estimated PCD: 2023-12-30
Clinical trial
A Multicenter, Single-group Phase II Clinical Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of Multiple Subcutaneous Injections of SHR-1703 in Eosinophilic Asthma PatientsStatus: Not yet recruiting, Estimated PCD: 2027-12-01